Keywords: ligand, targretin, stabilizes, cancer, studies, show, clinical

Ligand's Targretin Stabilizes Cancer, Studies Show

Article | 06 May 1996

Clinical investigators evaluating Ligand's retinoid product Targretin (LGD1069) oral capsules in patients with advanced cancers have reported stabilization of disease ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

bexarotene

Targretin

Nystatin

Tretinoin

Vesanoid

Go to drug listing